Rallybio Corp short interest in 2024
In 2024, Rallybio Corp's disclosed short interest ran from 1.97% of shares outstanding on 12 Jan 2024 to 0.85% on 31 Dec 2024, a change of -1.12 percentage points. The year's high was 7.84% on 15 Apr 2024 and its low 0.81% on 13 Dec 2024, averaging 2.59% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 13.82 days on 30 Sep 2024. Full history: Rallybio Corp.
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 1.97% (12 Jan 2024)
- End of year
- 0.85% (31 Dec 2024)
- Change
- -1.12 pp
- High
- 7.84% (15 Apr 2024)
- Low
- 0.81% (13 Dec 2024)
- Average
- 2.59%
- Highest days to cover
- 13.82 (30 Sep 2024)
- SEC filings marked
- 9
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 1.97% | 4.23 | |
| 31 Jan 2024 | 1.99% | 2.95 | |
| 15 Feb 2024 | 2.85% | 2.73 | results (8-K) |
| 29 Feb 2024 | 3.17% | 5.26 | |
| 15 Mar 2024 | 3.39% | 9.84 | 10-K filed, results (8-K) |
| 28 Mar 2024 | 3.47% | 10.70 | |
| 15 Apr 2024 | 7.84% | 1.00 | |
| 30 Apr 2024 | 5.18% | 5.54 | |
| 15 May 2024 | 4.61% | 8.85 | 10-Q filed, results (8-K) |
| 31 May 2024 | 4.67% | 7.29 | |
| 14 Jun 2024 | 4.54% | 12.61 | |
| 28 Jun 2024 | 3.77% | 2.40 | |
| 15 Jul 2024 | 1.60% | 3.42 | |
| 31 Jul 2024 | 1.55% | 6.38 | |
| 15 Aug 2024 | 1.50% | 7.55 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 1.34% | 7.13 | |
| 13 Sep 2024 | 1.40% | 10.20 | |
| 30 Sep 2024 | 1.40% | 13.82 | |
| 15 Oct 2024 | 1.29% | 8.54 | |
| 31 Oct 2024 | 1.12% | 4.75 | |
| 15 Nov 2024 | 0.88% | 5.17 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 0.85% | 5.96 | |
| 13 Dec 2024 | 0.81% | 3.06 | |
| 31 Dec 2024 | 0.85% | 2.77 |
See also: Rallybio Corp's full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.